These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3290703)

  • 21. Creutzfeldt-Jakob disease.
    de Villemeur TB
    Handb Clin Neurol; 2013; 112():1191-3. PubMed ID: 23622328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 23. Pituitary growth hormone from human cadavers: neurologic disease in ten recipients.
    Rappaport EB; Graham DJ
    Neurology; 1987 Jul; 37(7):1211-3. PubMed ID: 3474545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society, May 1985.
    J Pediatr; 1985 Jul; 107(1):10-2. PubMed ID: 3891943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Macario ME; Vaisman M; Buescu A; Moura Neto V; Araujo HM; Chagas C
    BMJ; 1991 May; 302(6785):1149. PubMed ID: 2043794
    [No Abstract]   [Full Text] [Related]  

  • 26. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins.
    Blisard KS; Davis LE; Harrington MG; Lovell JK; Kornfeld M; Berger ML
    J Neurol Sci; 1990 Oct; 99(1):75-81. PubMed ID: 2250174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
    Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
    Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iatrogenic Creutzfeldt-Jakob disease.
    Kobayashi A; Kitamoto T; Mizusawa H
    Handb Clin Neurol; 2018; 153():207-218. PubMed ID: 29887137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired Creutzfeldt-Jakob disease (CJD)--Kuru, iatrogenic CJD, variant CJD].
    Sanjo N
    Nihon Rinsho; 2007 Aug; 65(8):1438-45. PubMed ID: 17695281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
    Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
    Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathological findings in new variant CJD and experimental transmission of BSE.
    Ironside JW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
    Mitrova E; Belay G
    Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pituitary growth hormone (hGH) and Creutzfeldt-Jakob disease: results of an epidemiological survey in France, 1986.
    Goujard J; Entat M; Maillard F; Mugnier E; Rappaport R; Job JC
    Int J Epidemiol; 1988 Jun; 17(2):423-7. PubMed ID: 3042652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jacob disease].
    Gurau C; Zeghoudi AC; Atlaoui-Rabia S; Charitanski D; Mallecourt J
    Presse Med; 2005 Sep; 34(15):1080-1. PubMed ID: 16334885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Creutzfeldt-Jakob disease: report of a case].
    Kouyoumdjian JA; Meneghette C; Tognola WA; Fonseca MG; Costa Rde B
    Arq Neuropsiquiatr; 1987 Mar; 45(1):53-9. PubMed ID: 3300614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.
    Mikol J; Deslys JP; Zou WQ; Xiao W; Brown P; Budka H; Goutieres F
    Clin Neuropathol; 2012; 31(3):127-34. PubMed ID: 22551916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease with reference to the safety of pituitary growth hormone.
    Bannister BA; McCormick A
    J Infect; 1987 Jan; 14(1):7-12. PubMed ID: 3546511
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ; Ironside JW; Shalet SM
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic Creutzfeldt-Jakob disease.
    Rappaport EB
    Neurology; 1987 Sep; 37(9):1520-2. PubMed ID: 3306455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creutzfeldt-Jakob disease: further similarities with kuru.
    Adams H; Beck E; Shenkin AM
    J Neurol Neurosurg Psychiatry; 1974 Feb; 37(2):195-200. PubMed ID: 4362244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.